Image de couverture de livre

Viral hepatitis caused by occupational accidents: distribution of cases in Brazil, 2007-2014

Fuente: Redalyc

Enregistré dans:

Détails bibliographiques
Auteur principal:	Técia Maria Santos Carneiro e Cordeiro
Format:	Artículo científico
Langue:	en
Publié:	Universidade de Santa Cruz do Sul 2021
Sujets:	Salud Viral Human Spatio Hepatitis Accidents
Accès en ligne:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5 Acceder al recurso 6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A better regulation is required in viral hepatitis smartphone applications
par: M.ª R. Cantudo-Cuenca
Publié: (2014)

Factors affecting quality of life in hepatitis B patients in Herat, Afghanistan: A case–control study
par: Nasar Ahmad Shayan, et autres
Publié: (2024)

Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero‐surveys in 2007 and 2019
par: Tesfa Sewunet Alamneh, et autres
Publié: (2024)

Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States
par: David W. Hutton, et autres
Publié: (2024)

Racial discrimination, knowledge, and health outcomes: The mediating role of hepatitis B‐related stigma among patients with chronic hepatitis B
par: Julia G. Katcher, et autres
Publié: (2024)

Viral Hepatitis B, C and Delta in Greenland: A National Cross‐Sectional Study
par: Carina Nørskov Naustdal, et autres
Publié: (2026)

Prevalence of hepatitis C among pregnant women in an Appalachian population
par: Taylor S. Pollock, et autres
Publié: (2024)

Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase
par: Lung‐Yi Mak, et autres
Publié: (2024)

Direct‐acting antivirals in women of reproductive age infected with hepatitis C virus
par: Krystyna Dobrowolska, et autres
Publié: (2024)

Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies
par: SeyedehFatemeh Mousavi, et autres
Publié: (2024)

High prevalence of hepatitis B virus among MSM living with HIV in India
par: Hussain Syed Iqbal, et autres
Publié: (2024)

Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir
par: Sonia Chelouah, et autres
Publié: (2025)

Hepatitis after gene therapy, what are the possible causes?
par: Ann Maina, et autres
Publié: (2024)

Regarding the predictive role of CXCL16 in liver inflammation in chronic hepatitis B patients
par: Juanjuan Zhang, et autres
Publié: (2024)

Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city
par: Riying Lv, et autres
Publié: (2024)

An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis
par: Robert J. Wong, et autres
Publié: (2024)

Peer support for people living with hepatitis B virus—A foundation for treatment expansion
par: Louise O. Downs, et autres
Publié: (2024)

Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication
par: Shanmugam Saravanan, et autres
Publié: (2024)

Incidence of primary hepatitis C infection among people who inject drugs during 2012–2020 in Athens, Greece
par: Sotirios Roussos, et autres
Publié: (2024)

Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada
par: B. Wolfson‐Stofko, et autres
Publié: (2024)

A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a safety‐net hospital
par: Krysta Frye, et autres
Publié: (2024)

Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play?
par: Cristina Stasi, et autres
Publié: (2024)

Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta‐analysis
par: Fajuan Rui, et autres
Publié: (2024)

Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community
par: Jennifer R. Havens, et autres
Publié: (2024)

Elevation of S2‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma
par: Carlos Oltmanns, et autres
Publié: (2024)

Barriers and enablers to people‐centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study
par: Bethany Holt, et autres
Publié: (2024)

Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population‐based study
par: Golasa Samadi Kochaksaraei, et autres
Publié: (2024)

Genetic substructure and host‐specific natural selection trend across vaccine‐candidate ORF‐2 capsid protein of hepatitis‐E virus
par: Nasir Khan, et autres
Publié: (2024)

The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis
par: Bing Chen, et autres
Publié: (2024)

Preferences and feasibility of long‐acting technologies for treatment of hepatitis C virus in low‐ and middle‐income countries: A survey of providers and policymakers
par: Neil Gupta, et autres
Publié: (2024)

Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real‐world data
par: Wei Qin, et autres
Publié: (2024)

Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study
par: Hind A. Beydoun, et autres
Publié: (2024)

Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs
par: Mark S. Sulkowski, et autres
Publié: (2024)

Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374)
par: Magdalena Meszaros, et autres
Publié: (2024)

Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
par: Liandong Wu, et autres
Publié: (2024)

Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B
par: Mina S. Farag, et autres
Publié: (2024)

A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022
par: Huma Qureshi, et autres
Publié: (2024)

HCV Testing and Treatment of Adults in the United States: 2014 Through 2021—Data From Two National Commercial Testing Laboratories
par: Marc G. Ghany, et autres
Publié: (2025)

Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update
par: Pietro Lampertico, et autres
Publié: (2025)

Human Herpesvirus 6 in Acute Liver Failure: Leading Role, Supporting Actor or Innocent Bystander? A Case Series, Narrative Review and Management Algorithm Proposal
par: Andrés Conthe, et autres
Publié: (2025)